Literature DB >> 28498367

Initiation and execution mechanisms of necroptosis: an overview.

Sasker Grootjans1,2, Tom Vanden Berghe1,2, Peter Vandenabeele1,2.   

Abstract

Necroptosis is a form of regulated cell death, which is induced by ligand binding to TNF family death domain receptors, pattern recognizing receptors and virus sensors. The common feature of these receptor systems is the implication of proteins, which contain a receptor interaction protein kinase (RIPK) homology interaction motif (RHIM) mediating recruitment and activation of receptor-interacting protein kinase 3 (RIPK3), which ultimately activates the necroptosis executioner mixed lineage kinase domain-like (MLKL). In case of the TNF family members, the initiator is the survival- and cell death-regulating RIPK1 kinase, in the case of Toll-like receptor 3/4 (TLR3/4), a RHIM-containing adaptor, called TRIF, while in the case of Z-DNA-binding protein ZBP1/DAI, the cytosolic viral sensor itself contains a RHIM domain. In this review, we discuss the different protein complexes that serve as nucleation platforms for necroptosis and the mechanism of execution of necroptosis. Transgenic models (knockout, kinase-dead knock-in) and pharmacologic inhibition indicate that RIPK1, RIPK3 or MLKL are implicated in many inflammatory, degenerative and infectious diseases. However, the conclusion of necroptosis being solely involved in the etiology of diseases is blurred by the pleiotropic roles of RIPK1 and RIPK3 in other cellular processes such as apoptosis and inflammasome activation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28498367      PMCID: PMC5520172          DOI: 10.1038/cdd.2017.65

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  151 in total

1.  RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein.

Authors:  Akhil Rajput; Andrew Kovalenko; Konstantin Bogdanov; Seung-Hoon Yang; Tae-Bong Kang; Jin-Chul Kim; Jianfang Du; David Wallach
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

2.  A morphologically conserved nonapoptotic program promotes linker cell death in Caenorhabditis elegans.

Authors:  Mary C Abraham; Yun Lu; Shai Shaham
Journal:  Dev Cell       Date:  2007-01       Impact factor: 12.270

3.  Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis.

Authors:  X-N Wu; Z-H Yang; X-K Wang; Y Zhang; H Wan; Y Song; X Chen; J Shao; J Han
Journal:  Cell Death Differ       Date:  2014-06-06       Impact factor: 15.828

4.  Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.

Authors:  Kim Newton; Debra L Dugger; Katherine E Wickliffe; Neeraj Kapoor; M Cristina de Almagro; Domagoj Vucic; Laszlo Komuves; Ronald E Ferrando; Dorothy M French; Joshua Webster; Merone Roose-Girma; Søren Warming; Vishva M Dixit
Journal:  Science       Date:  2014-02-20       Impact factor: 47.728

5.  Regulation of Kv4.3 currents by Ca2+/calmodulin-dependent protein kinase II.

Authors:  Gerard P Sergeant; Susumu Ohya; James A Reihill; Brian A Perrino; Gregory C Amberg; Yuji Imaizumi; Burton Horowitz; Kenton M Sanders; Sang Don Koh
Journal:  Am J Physiol Cell Physiol       Date:  2004-09-29       Impact factor: 4.249

6.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

Authors:  S M Laster; J G Wood; L R Gooding
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

7.  Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice.

Authors:  Scott B Berger; Viera Kasparcova; Sandy Hoffman; Barb Swift; Lauren Dare; Michelle Schaeffer; Carol Capriotti; Michael Cook; Joshua Finger; Angela Hughes-Earle; Philip A Harris; William J Kaiser; Edward S Mocarski; John Bertin; Peter J Gough
Journal:  J Immunol       Date:  2014-05-12       Impact factor: 5.422

8.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

9.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

10.  RIPK1 prevents aberrant ZBP1-initiated necroptosis.

Authors:  Tom Vanden Berghe; William J Kaiser
Journal:  Oncotarget       Date:  2017-01-03
View more
  146 in total

1.  Induction and Detection of Necroptotic Cell Death in Mammalian Cell Culture.

Authors:  Mikhail Chesnokov; Imran Khan; Ilana Chefetz
Journal:  Methods Mol Biol       Date:  2021

2.  Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity.

Authors:  Annelise G Snyder; Nicholas W Hubbard; Michelle N Messmer; Sigal B Kofman; Cassidy E Hagan; Susana L Orozco; Kristy Chiang; Brian P Daniels; David Baker; Andrew Oberst
Journal:  Sci Immunol       Date:  2019-06-21

Review 3.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

4.  Autophagy, apoptosis, and mitochondria: molecular integration and physiological relevance in skeletal muscle.

Authors:  Darin Bloemberg; Joe Quadrilatero
Journal:  Am J Physiol Cell Physiol       Date:  2019-04-24       Impact factor: 4.249

Review 5.  Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.

Authors:  Holly Anderton; Ian P Wicks; John Silke
Journal:  Nat Rev Rheumatol       Date:  2020-07-08       Impact factor: 20.543

6.  Necroptosis of infiltrated macrophages drives Yersinia pestis dispersal within buboes.

Authors:  Mohammad Arifuzzaman; W X Gladys Ang; Hae Woong Choi; Matthew L Nilles; Ashley L St John; Soman N Abraham
Journal:  JCI Insight       Date:  2018-09-20

Review 7.  Collateral damage: necroptosis in the development of lung injury.

Authors:  Hilary Faust; Nilam S Mangalmurti
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-27       Impact factor: 5.464

8.  Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage.

Authors:  Amy C Hart; Lynn Abell; Junqing Guo; Michael E Mertzman; Ramesh Padmanabha; John E Macor; Charu Chaudhry; Hao Lu; Kevin O'Malley; Patrick J Shaw; Carolyn Weigelt; Matthew Pokross; Kevin Kish; Kyoung S Kim; Lyndon Cornelius; Andrew E Douglas; Deepa Calambur; Ping Zhang; Brian Carpenter; William J Pitts
Journal:  ACS Med Chem Lett       Date:  2019-05-06       Impact factor: 4.345

9.  Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis.

Authors:  Dan E McNamara; Giovanni Quarato; Cliff S Guy; Douglas R Green; Tudor Moldoveanu
Journal:  J Vis Exp       Date:  2018-08-07       Impact factor: 1.355

Review 10.  The Microenvironment of Tongue Cancer.

Authors:  Want Tao; Zeng Li-Juan; Li Kan; Li Jing-Yuan; Liu Xiang-Qi; Liang Yu-Jie
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.